Annual D&A
$3.05B$210.10M-6.45%
Summary
- Current Value
- As of today, GSK annual D&A is $3.05B, down -6.45% on
- Historical Performance
- GSK annual D&A is up +15.31% over the past 3 years, up +1.15% over the past 5 years
- All-Time High Comparison
- GSK annual D&A is currently -6.45% below its historical high of $3.26B set on
- 3-Year Low Comparison
- GSK annual D&A is +15.31% above its 3-year low of $2.64B reached on an earlier date
- Sector Comparison
- GSK annual D&A is higher than 98.65% of companies in Healthcare sector
Depreciation & Amortization Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual D&A | $3.05B | -6.5% | +15.3% | +1.1% | +17.7% | |
| Quarterly D&A | $623.84M | -39.8% | -19.8% | +25.3% | +199.5% | |
| TTM D&A | $4.59B | +9.4% | +51.6% | +40.5% | +120.6% | |
| Price | $50.73 | +38.5% | +39.8% | +30.3% | +15.4% | |
| Annual SG&A | $1.24B | +389.6% | +423.8% | +136.8% | -93.8% | |
| Annual Total Expenses | $35.52B | -3.5% | +16.0% | -2.3% | -14.0% | |
| Annual Operating Expenses | $21.78B | +5.0% | +38.4% | +13.7% | -10.1% | |
| Annual Revenue | $43.05B | +7.4% | +19.2% | -1.5% | -1.8% |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $3.26B | -6.5% | |
| 5Y | $3.26B | -6.5% | |
| All | $3.26B | -6.5% |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $2.64B | N/A | +15.3% |
| 5Y | $2.64B | +15.3% | |
| All | $279.40M | +991.5% |
Depreciation & Amortization History
FAQ
What is the current annual D&A of GSK?
As of today, GSK annual D&A is $3.05B
What is 1-year change in GSK annual D&A?
GSK annual D&A is down -6.45% year-over-year
What is 3-year change in GSK annual D&A?
GSK annual D&A is up +15.31% over the past 3 years
How far is GSK annual D&A from its all-time high?
GSK annual D&A is currently -6.45% below its historical high of $3.26B set on December 31, 2024
How does GSK annual D&A rank versus sector peers?
GSK annual D&A is higher than 98.65% of companies in Healthcare sector
When is GSK next annual earnings release?
As of today, the next annual earnings release for GSK has not been scheduled
Quarterly D&A
$623.84M$764.79M-55.08%
Summary
- Current Value
- As of today, GSK quarterly D&A is $623.84M, down -55.08% on
- Historical Performance
- GSK quarterly D&A is down -39.81% year-over-year, down -19.78% over the past 3 years
- All-Time High Comparison
- GSK quarterly D&A is currently -81.80% below its historical high of $3.43B set on
- 3-Year Low Comparison
- GSK quarterly D&A is +8.84% above its 3-year low of $573.18M reached on
- Sector Comparison
- GSK quarterly D&A is higher than 98.18% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly D&A | $623.84M | -55.1% | -39.8% | -19.8% | +25.3% | |
| Annual D&A | $3.05B | – | -6.5% | +15.3% | +1.1% | |
| TTM D&A | $4.59B | -8.3% | +9.4% | +51.6% | +40.5% | |
| Price | $50.73 | -13.3% | +38.5% | +39.8% | +30.3% | |
| Quarterly SG&A | $2.86B | -18.6% | +9.5% | +9.7% | -14.7% | |
| Quarterly Total Expenses | $7.94B | -25.2% | +7.0% | +19.6% | -9.3% | |
| Quarterly Operating Expenses | $4.85B | -27.2% | +11.7% | +20.6% | +1.5% | |
| Quarterly Revenue | $10.28B | -10.3% | +8.6% | +21.7% | +0.5% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.52B | -59.1% | |
| 3Y | $1.52B | -59.1% | |
| 5Y | $1.52B | -59.1% | |
| All | $3.43B | -81.8% |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $623.84M | at low | |
| 3Y | $573.18M | +8.8% | |
| 5Y | -$74.64M | +935.8% | |
| All | -$1.47B | +142.4% |
Quarterly D&A History
FAQ
What is the current quarterly D&A of GSK?
As of today, GSK quarterly D&A is $623.84M
What is GSK quarterly D&A most recent change?
GSK quarterly D&A was down -55.08% on March 31, 2026
What is 1-year change in GSK quarterly D&A?
GSK quarterly D&A is down -39.81% year-over-year
How far is GSK quarterly D&A from its all-time high?
GSK quarterly D&A is currently -81.80% below its historical high of $3.43B set on December 31, 2020
How does GSK quarterly D&A rank versus sector peers?
GSK quarterly D&A is higher than 98.18% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
TTM D&A
$4.59B$412.58M-8.26%
Summary
- Current Value
- As of today, GSK TTM D&A is $4.59B, down -8.26% on
- Historical Performance
- GSK TTM D&A is up +9.38% year-over-year, up +51.64% over the past 3 years
- All-Time High Comparison
- GSK TTM D&A is currently -22.94% below its historical high of $5.95B set on
- 3-Year Low Comparison
- GSK TTM D&A is +126.91% above its 3-year low of $2.02B reached on
- Sector Comparison
- GSK TTM D&A is higher than 99.29% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM D&A | $4.59B | -8.3% | +9.4% | +51.6% | +40.5% | |
| Annual D&A | $3.05B | – | -6.5% | +15.3% | +1.1% | |
| Quarterly D&A | $623.84M | -55.1% | -39.8% | -19.8% | +25.3% | |
| Price | $50.73 | -13.3% | +38.5% | +39.8% | +30.3% | |
| TTM SG&A | $54.55B | +354.8% | +287.7% | +421.0% | +280.6% | |
| TTM Revenue | $43.93B | +1.9% | +9.2% | +25.5% | +3.6% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $5.00B | -8.3% | |
| 3Y | $5.00B | -8.3% | |
| 5Y | $5.95B | -22.9% | |
| All | $5.95B | -22.9% |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $4.19B | N/A | +9.4% |
| 3Y | $2.02B | +126.9% | |
| 5Y | $2.02B | +126.9% | |
| All | -$826.51M | +654.8% |
TTM D&A History
FAQ
What is the current TTM D&A of GSK?
As of today, GSK TTM D&A is $4.59B
What is GSK TTM D&A most recent change?
GSK TTM D&A was down -8.26% on March 31, 2026
What is 1-year change in GSK TTM D&A?
GSK TTM D&A is up +9.38% year-over-year
How far is GSK TTM D&A from its all-time high?
GSK TTM D&A is currently -22.94% below its historical high of $5.95B set on September 30, 2021
How does GSK TTM D&A rank versus sector peers?
GSK TTM D&A is higher than 99.29% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
Data Sources & References
- GSK Official Website www.gsk.com
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk